FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19

FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19

The U.S. Food and Drug Administration (“FDA”) recently announced that its Vaccines and Related Biological Products Advisory Committee (“VRBPAC”) will hold a meeting on January 26, 2023 to consider the future vaccination regimens addressing COVID-19. A copy of the meeting notice can be found here.